 |
Schering-Plough's Hassan sanguine over healthcare reforms
Monday 1 December 2008
Christopher Spillane - Reporter
Fred Hassan, CEO of Schering-Plough, holds little fear over the potential impact on the pharmaceutical industry of any healthcare reforms that might be sought by a liberal US Senate after president-elect Barack Obama enters office on January 20th, 2009.
Concerns about proposals to introduce a near universal healthcare policy and a host of cost-cutting reforms to help the US negotiate the worsening economy are weighing on some analysts' minds. It is believed that the Democrats could use their majority to introduce price controls on prescription drugs.
Login to view the full article
- Not a subscriber? Request a FREE trial
- Subscribe to Scrip
- Email to a friend
Related Scrip Articles
Comments
No Comments Yet
About Scrip
Scrip World Pharmaceutical News provides you with high quality news coverage of pharma and biotech and also gives you strategic data and analysis.
Benefits include:
›› Daily email headlines
›› Searchable news
archive
›› Weekly copies of Scrip
›› Bespoke Scrip supplements
›› Plus the Scrip Yearbook
and Scrip League Tables
Scrip Awards 2008
The best and brightest of the pharmaceutical and biotech industries were celebrated at a glittering ceremony in London at the 2008 Scrip Awards.
Read the full story
Scrip Directory
Scrip Directory 2008
Search over 20,000 international contacts and access potential business opportunities
© Informa plc. All rights reserved. This site is owned and operated by Informa plc ("Informa") whose registered office is
Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
